Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2017 1
2018 4
2019 13
2020 9
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations.
Gisondi P, Talamonti M, Chiricozzi A, Piaserico S, Amerio P, Balato A, Bardazzi F, Calzavara Pinton P, Campanati A, Cattaneo A, Dapavo P, De Simone C, Dini V, Fargnoli MC, Flori ML, Galluzzo M, Guarneri C, Lasagni C, Loconsole F, Lo Schiavo A, Malagoli P, Malara G, Mercuri SR, Musumeci ML, Naldi L, Papini M, Parodi A, Potenza C, Prignano F, Rongioletti F, Stingeni L, Tiberio R, Venturini M, Bianchi L, Costanzo A, Cusano F, Girolomoni G, Offidani AM, Peris K. Gisondi P, et al. Among authors: malagoli p. Dermatol Ther (Heidelb). 2021 Feb;11(1):235-252. doi: 10.1007/s13555-020-00475-8. Epub 2021 Jan 11. Dermatol Ther (Heidelb). 2021. PMID: 33426634 Free PMC article.
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: AĀ Northern Italy experience.
Gisondi P, Piaserico S, Naldi L, Dapavo P, Conti A, Malagoli P, Marzano AV, Bardazzi F, Gasperini M, Cazzaniga S, Costanzo A; collaborators in the studies of COVID-19 pandemic. Gisondi P, et al. Among authors: malagoli p. J Allergy Clin Immunol. 2021 Feb;147(2):558-560.e1. doi: 10.1016/j.jaci.2020.10.032. Epub 2020 Nov 5. J Allergy Clin Immunol. 2021. PMID: 33160968 Free PMC article.
TNF-Ī± inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis.
Gisondi P, Geat D, Conti A, Dapavo P, Piaserico S, De Simone C, Bianchi L, Costanzo A, Malagoli P, Malara G, Micali G, Naldi L, Offidani A, Patrizi A, Prignano F, Parodi A, Rongioletti F, Calzavara-Pinton P, Girolomoni G. Gisondi P, et al. Among authors: malagoli p. Expert Rev Clin Immunol. 2020 Jun;16(6):591-598. doi: 10.1080/1744666X.2020.1771182. Epub 2020 Jun 4. Expert Rev Clin Immunol. 2020. PMID: 32419534 Review.
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis.
Scala E, Megna M, Amerio P, Argenziano G, Babino G, Bardazzi F, Bianchi L, Caldarola G, Campanati A, CannavĆ² SP, Chiricozzi A, Conti A, Damiani G, Dapavo P, De Simone C, Esposito M, Fabbrocini G, Fargnoli MC, Ferrara F, Fidanza R, Gualdi G, Guarneri C, Hansel K, Malagoli P, Malara G, Micali G, Mugheddu C, Musumeci ML, Odorici G, Offidani A, Pescitelli L, Prignano F, Raimondo A, Ribero S, Rongioletti F, Stingeni L, TrifirĆ² C, Zanframundo S, Balato A. Scala E, et al. Among authors: malagoli p. PLoS One. 2020 Aug 12;15(8):e0237267. doi: 10.1371/journal.pone.0237267. eCollection 2020. PLoS One. 2020. PMID: 32785291 Free PMC article.
Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data.
Damiani G, Kridin K, Pacifico A, Malagoli P, Pigatto PDM, Finelli R, Taccone FS, Peluso L, Conic RRZ, Bragazzi NL; Young Dermatologists Italian Network, Fiore M. Damiani G, et al. Among authors: malagoli p. J Dermatolog Treat. 2020 Oct 28:1-4. doi: 10.1080/09546634.2020.1840502. Online ahead of print. J Dermatolog Treat. 2020. PMID: 33084462
34 results